Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing

R Randall, Timothy A. Damrom, Cheryl M. Coffin, Jeffrey D. Bastar, David E. Joyner

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Genetic expression profiling is enabling investigators to discover new diagnostic and possibly therapeutic pathways in sarcoma biology. To draw substantial conclusions from these molecular analyses, adequate tissue samples must be accrued. Beyond cohort size, the most variable and limiting aspect of doing gene expression analyses on fresh human tissue is the preservation of labile ribonucleic acids extracted from clinical specimens. We have developed a novel retrieval protocol that is readily amenable to the clinical constraints placed on surgeons and pathologists that minimizes variables that can corrupt ribonucleic acid fidelity. We evaluate critically genomic message integrity of mesenchymal tumors derived from transcontinental inter-institutional collaboration. Intact total ribonucleic acid was isolated and assessed for quality and quantity. Ribosomal RNA integrity was quantified using a bioanalyzer. Ribonucleic acid from 42 mesenchymal tumors was isolated and quantified, with selected samples amplified. The mean ribosomal ratios for collaborative institutions ranged from 1.0 to 1.18. Samples remained at 4°C before processing from 1 to 17 days. Tumors stabilized using this protocol retained total ribonucleic acid integrity suitable for amplification and genomic expression analysis regardless of the institutional source or preprocessing duration, enabling a potential consortium of investigators to collaborate in the expression profiling of sarcomas. Level of Evidence: Diagnostic study, Level III-3 (no consistently applied gold standard).

Original languageEnglish (US)
Pages (from-to)149-157
Number of pages9
JournalClinical Orthopaedics and Related Research
Issue number438
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Freezing
RNA
Neoplasms
Sarcoma
Research Personnel
Tissue Preservation
Ribosomal RNA
Gene Expression
Therapeutics

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing. / Randall, R; Damrom, Timothy A.; Coffin, Cheryl M.; Bastar, Jeffrey D.; Joyner, David E.

In: Clinical Orthopaedics and Related Research, No. 438, 01.09.2005, p. 149-157.

Research output: Contribution to journalArticle

Randall, R ; Damrom, Timothy A. ; Coffin, Cheryl M. ; Bastar, Jeffrey D. ; Joyner, David E. / Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing. In: Clinical Orthopaedics and Related Research. 2005 ; No. 438. pp. 149-157.
@article{0ea530bbb0e04835a5e26ceee0bc87ca,
title = "Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing",
abstract = "Genetic expression profiling is enabling investigators to discover new diagnostic and possibly therapeutic pathways in sarcoma biology. To draw substantial conclusions from these molecular analyses, adequate tissue samples must be accrued. Beyond cohort size, the most variable and limiting aspect of doing gene expression analyses on fresh human tissue is the preservation of labile ribonucleic acids extracted from clinical specimens. We have developed a novel retrieval protocol that is readily amenable to the clinical constraints placed on surgeons and pathologists that minimizes variables that can corrupt ribonucleic acid fidelity. We evaluate critically genomic message integrity of mesenchymal tumors derived from transcontinental inter-institutional collaboration. Intact total ribonucleic acid was isolated and assessed for quality and quantity. Ribosomal RNA integrity was quantified using a bioanalyzer. Ribonucleic acid from 42 mesenchymal tumors was isolated and quantified, with selected samples amplified. The mean ribosomal ratios for collaborative institutions ranged from 1.0 to 1.18. Samples remained at 4°C before processing from 1 to 17 days. Tumors stabilized using this protocol retained total ribonucleic acid integrity suitable for amplification and genomic expression analysis regardless of the institutional source or preprocessing duration, enabling a potential consortium of investigators to collaborate in the expression profiling of sarcomas. Level of Evidence: Diagnostic study, Level III-3 (no consistently applied gold standard).",
author = "R Randall and Damrom, {Timothy A.} and Coffin, {Cheryl M.} and Bastar, {Jeffrey D.} and Joyner, {David E.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1097/01.blo.0000179585.34727.80",
language = "English (US)",
pages = "149--157",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "438",

}

TY - JOUR

T1 - Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing

AU - Randall, R

AU - Damrom, Timothy A.

AU - Coffin, Cheryl M.

AU - Bastar, Jeffrey D.

AU - Joyner, David E.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Genetic expression profiling is enabling investigators to discover new diagnostic and possibly therapeutic pathways in sarcoma biology. To draw substantial conclusions from these molecular analyses, adequate tissue samples must be accrued. Beyond cohort size, the most variable and limiting aspect of doing gene expression analyses on fresh human tissue is the preservation of labile ribonucleic acids extracted from clinical specimens. We have developed a novel retrieval protocol that is readily amenable to the clinical constraints placed on surgeons and pathologists that minimizes variables that can corrupt ribonucleic acid fidelity. We evaluate critically genomic message integrity of mesenchymal tumors derived from transcontinental inter-institutional collaboration. Intact total ribonucleic acid was isolated and assessed for quality and quantity. Ribosomal RNA integrity was quantified using a bioanalyzer. Ribonucleic acid from 42 mesenchymal tumors was isolated and quantified, with selected samples amplified. The mean ribosomal ratios for collaborative institutions ranged from 1.0 to 1.18. Samples remained at 4°C before processing from 1 to 17 days. Tumors stabilized using this protocol retained total ribonucleic acid integrity suitable for amplification and genomic expression analysis regardless of the institutional source or preprocessing duration, enabling a potential consortium of investigators to collaborate in the expression profiling of sarcomas. Level of Evidence: Diagnostic study, Level III-3 (no consistently applied gold standard).

AB - Genetic expression profiling is enabling investigators to discover new diagnostic and possibly therapeutic pathways in sarcoma biology. To draw substantial conclusions from these molecular analyses, adequate tissue samples must be accrued. Beyond cohort size, the most variable and limiting aspect of doing gene expression analyses on fresh human tissue is the preservation of labile ribonucleic acids extracted from clinical specimens. We have developed a novel retrieval protocol that is readily amenable to the clinical constraints placed on surgeons and pathologists that minimizes variables that can corrupt ribonucleic acid fidelity. We evaluate critically genomic message integrity of mesenchymal tumors derived from transcontinental inter-institutional collaboration. Intact total ribonucleic acid was isolated and assessed for quality and quantity. Ribosomal RNA integrity was quantified using a bioanalyzer. Ribonucleic acid from 42 mesenchymal tumors was isolated and quantified, with selected samples amplified. The mean ribosomal ratios for collaborative institutions ranged from 1.0 to 1.18. Samples remained at 4°C before processing from 1 to 17 days. Tumors stabilized using this protocol retained total ribonucleic acid integrity suitable for amplification and genomic expression analysis regardless of the institutional source or preprocessing duration, enabling a potential consortium of investigators to collaborate in the expression profiling of sarcomas. Level of Evidence: Diagnostic study, Level III-3 (no consistently applied gold standard).

UR - http://www.scopus.com/inward/record.url?scp=24344433834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344433834&partnerID=8YFLogxK

U2 - 10.1097/01.blo.0000179585.34727.80

DO - 10.1097/01.blo.0000179585.34727.80

M3 - Article

SP - 149

EP - 157

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 438

ER -